ScholarIQanswers from OpenAlex & ORCID
Pierce K. H. Chow
ResearcherPublications, citations & collaboration network
Pierce K. H. Chow is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Pierce K. H. Chow have?
ScholarIQindexed works
Pierce K. H. Chow has 610 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Pierce K. H. Chow have?
ScholarIQcitation count
Pierce K. H. Chow has 27,211 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Pierce K. H. Chow?
ScholarIQh-index
Pierce K. H. Chow has an h-index of 86 in OpenAlex.
What is the i10-index of Pierce K. H. Chow?
ScholarIQi10-index
Pierce K. H. Chow has an i10-index of 338 in OpenAlex.
What is the ORCID of Pierce K. H. Chow?
ScholarIQorcid
The ORCID for Pierce K. H. Chow is on the source record.
What is the OpenAlex record for Pierce K. H. Chow?
ScholarIQopenalex
The OpenAlex for Pierce K. H. Chow is on the source record.
What are the most-cited papers on Pierce K. H. Chow?
ScholarIQmost cited works
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei‐Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T.P. Poon, Shuichiro Shiina, Ann‐Lii Cheng, Jidong Jia, Shuntaro Obi, Kwang‐Hyub Han, Wasim Jafri, Pierce K. H. Chow, Seng Gee Lim, Yogesh Chawla, Unggul Budihusodo, Rino Alvani Gani, Cosmas Rinaldi Adithya Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Ahmed O. Kaseb, Masatoshi Kudo, Han Chu Lee, Adam C. Yopp, Jian Zhou, Lu Wang, Xiaoyu Wen, Jeong Heo, Won Young Tak, Shinichiro Nakamura, Kazushi Numata, Thomas Uguen, David Hsiehchen, Edward Cha, Stephen P. Hack, Qinshu Lian, Ning Ma, Jessica Spahn, Yulei Wang, Lyndia C. Wu, Pierce K. H. Chow, Alexander Thompson, Mark Danta, Pirooz Poursoltan, Andrew Ddembe Kiberu, Renuka Chittajallu, Siddarth Sood, Rudolf Stauber, Matthias Pinter, Markus Peck‐Radosavljevic, Jochen Decaestecker, Pieter‐Jan Cuyle, Gontran Verset, Hans Van Vlierberghe, Sérgio de Azevedo, Livia Andrade, Ademar Cunha Júnior, Luiza Dib Batista Bugiato Faria, Cheng Tzu Yen, Leandro M. Colli, Jamil Asselah, Petr Kavan, Vladimir Marquez, Mayur Brahmania, Qiang Li, Bao-Cai Xing, Yabing Guo, Zhendong Chen, Haitao Zhao, Tao Peng, Liming Wang, Lu Wang, Hongming Liu, Feixiang Wu, Lun–Xiu Qin, Qichang Zheng, Jieer Ying, Haitao Li, Tianfu Wen, Shukui Qin, Xiaoyu Wen, Yunpeng Liu, Minshan Chen, Boqing Wang, Yuxian Bai, Yifu He, Hong Zhao, Dong Zhou, Chaoliu Dai, Gao‐Jun Teng, Shuzhong Cui, Yi Gao, Xizhi Zhang, Zheng Lu, Tao Yin, Youming Ding, Weidong Jia, Yongxiang Xia, Beicheng Sun, Qiang Xia, Yufeng Yuan, Hui‐Chuan Sun, Xuetao Shi, A. Guzmán, Luis Corrales, Zdeněk Král, Peter Priester, Eugen Kubala, Jean Frédéric Blanc, Marc Bourlière, Jean Marie Péron, Christophe Borg, Jean–Pierre Bronowicki, Nathalie Ganne, Thomas Decaens, Thomas Uguen, Alexandra Heurgué
Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3
Yu Wang, Yiwei Lu, Soo Ting Toh, Wing‐Kin Sung, Patrick Tan, Pierce K. H. Chow, Alexander Chung, London L.P. Jooi, Caroline Lee
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai‐Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce K. H. Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen